Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-19 4:34 pm Purchase | 13G | SURROZEN INC SRZN | Stonepine Capital Management LLC | 199,158 6% | 199,158 (New Position) | View |
| 2024-02-14 10:01 am Sale | 13G | UROGEN PHARMA LTD URGN | Stonepine Capital Management LLC | 0 0% | -1,304,947 (Position Closed) | View |
| 2024-02-13 4:35 pm Sale | 13G | EXAGEN INC XGN | Stonepine Capital Management LLC | 669,684 3.9% | -184,358 (-21.59%) | View |
| 2024-02-13 4:34 pm Sale | 13G | XERIS BIOPHARMA HLDGS INC XERS | Stonepine Capital Management LLC | 5,937,000 4.3% | -5,258,189 (-46.97%) | View |
| 2024-02-13 4:33 pm Sale | 13G | THIRD HARMONIC BIO INC THRD | Stonepine Capital Management LLC | 0 0% | -2,152,968 (Position Closed) | View |
| 2024-02-13 4:32 pm Sale | 13G | SCYNEXIS INC SCYX | Stonepine Capital Management LLC | 1,355,186 3.6% | -1,422,691 (-51.22%) | View |
| 2024-02-13 4:31 pm Sale | 13G | REZOLUTE INC RZLT | Stonepine Capital Management LLC | 2,768,656 7% | -252,848 (-8.37%) | View |
| 2024-02-13 4:30 pm Sale | 13G | ATYR PHARMA INC LIFE | Stonepine Capital Management LLC | 482,258 0.8% | -4,260,904 (-89.83%) | View |
| 2024-02-13 4:29 pm Sale | 13G | IO BIOTECH INC IOBT | Stonepine Capital Management LLC | 3,641,345 5.4% | -309,271 (-7.83%) | View |
| 2024-02-13 4:28 pm Sale | 13G | GAMIDA CELL LTD GMDA | Stonepine Capital Management LLC | 3,000,000 2.2% | -6,854,158 (-69.56%) | View |
| 2024-02-13 4:27 pm Purchase | 13G | EVOLUS INC EOLS | Stonepine Capital Management LLC | 5,333,004 9.3% | 1,145,557 (+27.36%) | View |
| 2024-02-13 4:26 pm Sale | 13G | DELCATH SYS INC DCTH | Stonepine Capital Management LLC | 208,333 0.9% | -767,675 (-78.65%) | View |
| 2024-02-13 4:25 pm Purchase | 13G | AYTU BIOPHARMA INC PAR $0. AYTU | Stonepine Capital Management LLC | 565,484 9.99% | 1,642 (+0.29%) | View |
| 2024-02-13 4:24 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | Stonepine Capital Management LLC | 5,373,732 9.99% | -3,979 (-0.07%) | View |
| 2024-02-09 4:16 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Stonepine Capital Management LLC | 2,409,058 9.99% | 2,409,058 (New Position) | View |
| 2024-01-31 4:27 pm Purchase | 13G | CALCIMEDICA INC CALC | Stonepine Capital Management LLC | 1,045,204 9.7% | 1,045,204 (New Position) | View |
| 2023-08-24 11:53 am Purchase | 13G | GAMIDA CELL LTD GMDA | Stonepine Capital Management LLC | 9,854,158 7.9% | 9,854,158 (New Position) | View |
| 2023-08-16 4:15 pm Purchase | 13G | IO BIOTECH INC IOBT | Stonepine Capital Management LLC | 3,950,616 5.8% | 3,950,616 (New Position) | View |
| 2023-08-10 5:26 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | Stonepine Capital Management LLC | 5,377,711 9.99% | 5,377,711 (New Position) | View |
| 2023-06-26 5:03 pm Purchase | 13G | DELCATH SYS INC DCTH | Stonepine Capital Management LLC | 976,008 8.7% | 976,008 (New Position) | View |